Effects of Virtual Reality-Assisted Dual Task Training on Muscle Oxygenation in Patients W
Chronic Obstructive Pulmonary Disease (COPD) is a common but preventable disease that is associated with a chronic inflammatory response in the airways and lungs to noxious gases, often progressive, resulting in a persistent limitation of airflow. Chronic cough, dyspnea, and sputum production are the most common sympto
| Condition(s) | Chronic Obstructive Lung Disease |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Chronic Obstructive Pulmonary Disease (COPD) is a common but preventable disease that is associated with a chronic inflammatory response in the airways and lungs to noxious gases, often progressive, resulting in a persistent limitation of airflow. Chronic cough, dyspnea, and sputum production are the most common symptoms of the disease. Respiratory failure and decrease in physical activity seen in the later stages of the disease also negatively affect the participants' participation in daily life. COPD, which is an important health problem due to its increasing incidence, high prevalence, and associated social and economic costs, ranks fourth among the global causes of death. Cognitive and physical impairments are often associated with COPD prognosis. In the literature, a relationship was |
| Who can participate | Inclusion Criteria: * Diagnosis of COPD stage 2 or 3 according to GOLD classification * No orthopedic and/or neuromuscular conditions that would interfere with dual-task training * Ability to ambulate * Adequate cognitive level to participate in the training (Mini Mental State Examination score ≥ 23) * Voluntary participation Exclusion Criteria: * Presence of vestibular problems that would interfere with virtual reality applications * Visual impairments * Any medical condition contraindicating exercise participation * Being in an acute exacerbation period * Having an active infection * Diagnosis of cancer * Known cardiovascular disease |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Lead sponsor | Istinye University |
| Locations | Istanbul, Turkey (Türkiye) |
| Start date | 2025-07-12 |
| NCT ID | NCT07015216 |
| Official listing | https://clinicaltrials.gov/study/NCT07015216 |